Breaking News on Outsourcing Pharma
A bitter pill to swallow: young people dislike tablets more than old
Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.
Kemwell CEO says environmental efforts are worth the cost
Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost.
Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse
Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.
AlpVision's iPhone Tech Offers Authentication in War on Counterfeits
In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.
Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests
Excipient firms that skip lot testing or use alternative analysis methods should justify their decisions according to a new COA guide issued by IPEC Americas.
Is risk-based clinical trial monitoring too flexible for the regulators?
Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.